Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

US LAB, INC

NPI: 1730570987 · COSTA MESA, CA 92626 · Clinical Medical Laboratory · NPI assigned 02/10/2015

$167K
Total Medicaid Paid
16,264
Total Claims
15,475
Beneficiaries
26
Codes Billed
2018-01
First Month
2023-09
Last Month

Provider Details

Authorized OfficialUMBS, MATTHEW (CEO)
NPI Enumeration Date02/10/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,137 $21K
2019 1,426 $8K
2020 1,549 $17K
2021 1,713 $46K
2022 1,050 $55K
2023 389 $21K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 4,705 4,564 $131K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,553 3,351 $29K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 59 59 $690.83
80355 383 356 $522.74
80369 382 356 $514.55
80323 371 344 $510.89
80373 381 354 $500.41
80372 380 353 $476.17
80367 369 343 $475.05
80368 371 344 $453.40
80361 351 334 $422.62
80335 380 353 $297.88
80346 378 365 $214.67
80354 351 334 $176.07
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 55 48 $162.71
80345 380 364 $157.67
83992 218 215 $152.20
80348 351 334 $152.19
80362 350 333 $146.54
80356 365 351 $142.61
80358 349 333 $130.69
80349 352 332 $114.31
80365 347 331 $110.54
80324 362 342 $106.55
80359 362 342 $106.55
80353 359 340 $105.35